Related Experiment Videos
Clinical pharmacology of slow channel blocking agents
Progress in Cardiovascular Diseases
|September 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical implications of patient-provider agreements in opioid prescribing.
Current drug safety·2015
The practicing clinician and regulatory safety concerns.
Current drug safety·2013
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.
Diabetes technology & therapeutics·2002
Cardiodepressant actions of combined diltiazem and propranolol in dogs.
Journal of cardiovascular pharmacology·1994
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
Cardiovascular drugs and therapy·1990
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
Progress in cardiovascular diseases·2026
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.
Progress in cardiovascular diseases·2026
Obesity, lipids, inflammation, and healthy aging.
Progress in cardiovascular diseases·2026
Revascularization options for managing patients with multi-vessel coronary artery disease.
Progress in cardiovascular diseases·2026
One syndrome, many diseases: toward precision pharmacotherapy in acute respiratory distress syndrome.
Frontiers in pharmacology·2026
Use of Sildenafil Citrate for the Treatment of Erectile Dysfunction in Stallions: First Case Reports.
Reproduction in domestic animals = Zuchthygiene·2026
Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review.
Clinical, cosmetic and investigational dermatology·2026
Spatial pharmacology of anti-cancer immunomodulators: a comprehensive review.
Frontiers in pharmacology·2026
Opioid receptor agonist-antagonists in pain management: receptor specific mechanisms, dose response relationships, and clinical combination strategies.
Frontiers in pain research (Lausanne, Switzerland)·2026